July 16, 2019
Sens. Kirsten Gillibrand (D-N.Y.), Kamala Harris (D-Calif.), and Amy Klobuchar (D-Minn.), who each are seeking the 2020 Democratic nomination for president, have announced separate plans to address high prescription drug costs in the United States.
Evidence shows that urinary tract infections are becoming increasingly resistant to the routine course of antibiotics, leading to more serious illnesses, increased hospitalizations, and extended discomfort for patients.
July 15, 2019
Former Vice President Joe Biden, who is seeking the 2020 Democratic nomination for president, today unveiled a health reform plan that aims to build on and protect the Affordable Care Act by providing Americans with the option to enroll in a public health plan and expanding eligibility for subsidies to purchase exchange plans.
In the United States, the cannabis industry exists in a grey area that has made it difficult for researchers to examine the plant's potential medical benefits, but one Israel-based company is seeking to bridge the gap by providing evidence-based medical cannabis treatment plans.
July 11, 2019
The Trump administration has withdrawn its proposed rule to prohibit drugmakers from paying rebates to pharmacy benefit managers under federal health programs, a White House spokesperson confirmed Wednesday.
President Trump on Wednesday issued an executive order that calls on HHS to overhaul the kidney care and donation allocation process, and HHS shortly after unveiled new payment models for Medicare providers who manage patients with kidney disease and end-stage renal disease.
July 10, 2019
Tom Steyer, a billionaire and environmentalist, on Tuesday announced that he is seeking the 2020 Democratic nomination for president, and has said his campaign will call for achieving universal health coverage in the United States.
July 9, 2019
A federal judge on Monday struck down HHS' final rule to require drugmakers to disclose their products' list prices in consumer-directed television advertisements, blocking the rule from taking effect on Tuesday.
FDA approved a record high of 43 drugs through fast-track programs in 2018, representing 73% of new drugs approved by the agency last year and establishing a "new normal" that "is transforming medical decision-making for the seriously ill," according to the Wall Street Journal.
While many health systems struggle to implement price transparency tools, Allina Health in Minnesota has successfully implemented a tool that gives physicians real-time information about how much patients' prescriptions will cost.
Advisory Board. All rights reserved.